Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001720081-17-000006
Filing Date
2017-10-23
Accepted
2017-10-23 08:27:43
Documents
2
Period of Report
2017-10-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_150876164955148.html 3  
1 FORM 3 wf-form3_150876164955148.xml 3 1723
2 EXHIBIT 24 - LIMITED POWER OF ATTORNEY jounce-powerofattorneyfors.htm EX-24 4405
  Complete submission text file 0001720081-17-000006.txt   7465
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Issuer) CIK: 0001640455 (see all company filings)

EIN.: 454870634 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O JOUNCE THERAPEUTICS, INC. 780 MEMORIAL DRIVE CAMBRIDGE MA 02138
Business Address
Diaz Luis (Reporting) CIK: 0001720081 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37998 | Film No.: 171148297